Drug Trial Radar · NCT07761572
CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
Last checked: Nov 20, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
126
Planned (sponsor's estimate)
Start
Sep 15, 2026
Primary completion
Feb 2, 2029
Study completion Apr 30, 2029
Sponsor
- Lead sponsor
- Cereno Scientific ABIndustry
- Sponsor type
- Industry
- First posted
- Aug 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 2 study (EPIMODE) will evaluate the efficacy and safety of CS1 compared with placebo when added to standard-of-care therapy in participants with pulmonary arterial hypertension. Participants completing Treatment Period 1 (Week 36) will be re-randomized to continue or switch study treatment for Treatment Period 2 through Week 52.
Conditions
- Pulmonary Arterial Hypertension
Interventions
CS1Drug
160 mg delayed release capsules taken orally once daily in the evening
PlaceboDrug
Matching placebo capsules taken orally once daily in the evening
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in pulmonary vascular resistance (PVR)Time frame: Baseline to Week 36
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.